Lucigen, a Middleton biotechnology company, has received two Small Business Innovation Research grants totaling $350,000 from the National Institutes of Health.
The funds will help Lucigen develop better tools to identify which genes are being turned on in a cell at a particular moment, and that is expected to influence future drug development and personalized medicine.
They also will be used to develop a way to quickly screen for new enzymes that can multiply long strands of DNA. Lucigen will be working with Auburn University in Auburn, Ala., on that project.
Lucigen, established in 1998, specializes in discovering enzymes from hot springs in Yellowstone National Park and has 40 employees. The grants are not expected to result in additional staff.